It's been a great couple of years for the Melbourne-based medicinal cannabis company Medigrowth Australia Pty Ltd. Back in mid-2023, Medigrowth raised $3.2m in new capital on the Australian crowd-funding platform Birchal. The company had generated just under $1m in revenue in the previous twelve months, but average monthly sales were growing at 20-30% p.a.,…
4 WiseTech directors quit en masse this morning, and that was just the start of the bad news facing the company this morning just 2 days before it is due to release its annual results.
A recap of the WiseTech saga
Before we outline what happened today, let's bring investors up to speed to help newcomers…
Many investors will know technical analysis has become an increasingly important part of stock analysis, but they may not know how to read stock charts. Those investors need not fear - we have compiled this guide to technical analysis so you may be able to know what technical traders are watching for, and perhaps integrate…
In this article, we ask the question: how can you find the best stocks for retirement? Investing in stocks can be a great way to build wealth for retirement. However, not all stock sectors are suitable for investors investing for retirement. We think there are 4 that are best suited for retirees.
Best stocks for retirement
Generally,…
The $2.7bn Domain takeover bid stole the headlines today. Shares in Domain (predictably) surged from their $3.13 close the day before to match the $4.20 bid and more. Shares in major shareholder Nine Entertainment (ASX:NEC) increased as well, whilst shares in rival Rea Group (ASX:REA), which owns realestate.com.au, fell 10%.
The specifics of the Domain takeover…
NZX stocks typically are not on the radar of ASX investors (or any investors outside the Land of the Long White Cloud for that matter), unless they take up a place on the ASX. Some choose to remain dual-listed, others chose to make the ASX their primary home eventually like Xero (ASX:XRO) did.
The reasons for…
Some investors are worried that Peter Dutton wants to break up insurers. Not just because he is in with a chance at the forthcoming federal election, but his ambitions appear legitimate. You cannot say at least some investors are worried - Suncorp (ASX:SUN) fell over 20% in a single day earlier this week. How legitimate…
Recce Pharmaceuticals (ASX:RCE) has completed its Phase 2 ABSSSI Clinical Trial (Acute Bacterial Skin and Skin Structure Infections) for RECCE® 327 Topical Gel (R327G) and released the results earlier this week. The results were positive, and pave the way for commercialisation as early as 2026.
How Recce got to this point
Recce is a biotech company focused…
It is reporting season soon but unaudited results are being released ahead of that by many companies and some have even done so throughout the financial year.
How much weight should you place on unaudited results as an investor? Let's take a look at that question.
Unaudited results - what are they?
Audited results are independently verified…
Many investors are asking what ASX Stocks to buy when interest rates fall. When exactly interest rates will fall is anyone's guess, until earlier today (February 18, 2025) when rates were cut from 4.35% to 4.1%. Argue all you like about whether the RBA could've gone further or should've stayed put, but it did what…
